This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Free Online Activities

Pain and the Brain

Lesley M. Arnold, M.D.; Rakesh Jain, M.D., M.P.H.; and William M. Glazer, M.D., Moderator

Published: September 30, 2008

This CME activity is expired. For more CME activities, visit
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Article Abstract

Chronic pain is difficult to diagnose and treat, and is often comorbid with psychiatric conditions. Pain and mood disorders may share neurologic pathways and a neurochemical base. For example, depression is associated with abnormalities in serotonin and norepinephrine, neurotransmitters that also modulate the endogenous analgesic system. Further, co-occurring depression and pain may obscure a diagnosis of the other, secondary condition. Agents that inhibit pain signals and boost serotonin and norepinephrine levels, such as serotonin-norepinephrine reuptake inhibitors (SNRIs), may provide pain relief as well as alleviate psychiatric symptom. Psychotherapies and education should also be considered to help patients achieve optimal functioning. The pathophysiology, diagnosis, and treatment of pain and mood disorders are discussed in this video, which features case studies of and expert commentary on patients with diabetic neuropathy, lower back pain, and chronic widespread pain.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 69

Quick Links: Neurologic and Neurocognitive , Neurology


Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...